rs196295

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004281.4(BAG3):ā€‹c.1296A>Gā€‹(p.Val432=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.768 in 1,613,978 control chromosomes in the GnomAD database, including 478,889 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.76 ( 43760 hom., cov: 32)
Exomes š‘“: 0.77 ( 435129 hom. )

Consequence

BAG3
NM_004281.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:16

Conservation

PhyloP100: -0.550
Variant links:
Genes affected
BAG3 (HGNC:939): (BAG cochaperone 3) BAG proteins compete with Hip for binding to the Hsc70/Hsp70 ATPase domain and promote substrate release. All the BAG proteins have an approximately 45-amino acid BAG domain near the C terminus but differ markedly in their N-terminal regions. The protein encoded by this gene contains a WW domain in the N-terminal region and a BAG domain in the C-terminal region. The BAG domains of BAG1, BAG2, and BAG3 interact specifically with the Hsc70 ATPase domain in vitro and in mammalian cells. All 3 proteins bind with high affinity to the ATPase domain of Hsc70 and inhibit its chaperone activity in a Hip-repressible manner. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 10-119676850-A-G is Benign according to our data. Variant chr10-119676850-A-G is described in ClinVar as [Benign]. Clinvar id is 44777.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-119676850-A-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.55 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.778 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
BAG3NM_004281.4 linkuse as main transcriptc.1296A>G p.Val432= synonymous_variant 4/4 ENST00000369085.8 NP_004272.2
BAG3XM_005270287.2 linkuse as main transcriptc.1293A>G p.Val431= synonymous_variant 4/4 XP_005270344.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
BAG3ENST00000369085.8 linkuse as main transcriptc.1296A>G p.Val432= synonymous_variant 4/41 NM_004281.4 ENSP00000358081 P1

Frequencies

GnomAD3 genomes
AF:
0.756
AC:
114888
AN:
152038
Hom.:
43725
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.755
Gnomad AMI
AF:
0.623
Gnomad AMR
AF:
0.723
Gnomad ASJ
AF:
0.819
Gnomad EAS
AF:
0.519
Gnomad SAS
AF:
0.737
Gnomad FIN
AF:
0.738
Gnomad MID
AF:
0.775
Gnomad NFE
AF:
0.784
Gnomad OTH
AF:
0.749
GnomAD3 exomes
AF:
0.738
AC:
185417
AN:
251322
Hom.:
69356
AF XY:
0.744
AC XY:
101023
AN XY:
135856
show subpopulations
Gnomad AFR exome
AF:
0.753
Gnomad AMR exome
AF:
0.642
Gnomad ASJ exome
AF:
0.818
Gnomad EAS exome
AF:
0.515
Gnomad SAS exome
AF:
0.764
Gnomad FIN exome
AF:
0.742
Gnomad NFE exome
AF:
0.784
Gnomad OTH exome
AF:
0.761
GnomAD4 exome
AF:
0.770
AC:
1125074
AN:
1461822
Hom.:
435129
Cov.:
85
AF XY:
0.770
AC XY:
560117
AN XY:
727210
show subpopulations
Gnomad4 AFR exome
AF:
0.749
Gnomad4 AMR exome
AF:
0.653
Gnomad4 ASJ exome
AF:
0.818
Gnomad4 EAS exome
AF:
0.518
Gnomad4 SAS exome
AF:
0.765
Gnomad4 FIN exome
AF:
0.742
Gnomad4 NFE exome
AF:
0.785
Gnomad4 OTH exome
AF:
0.764
GnomAD4 genome
AF:
0.756
AC:
114978
AN:
152156
Hom.:
43760
Cov.:
32
AF XY:
0.752
AC XY:
55920
AN XY:
74384
show subpopulations
Gnomad4 AFR
AF:
0.755
Gnomad4 AMR
AF:
0.723
Gnomad4 ASJ
AF:
0.819
Gnomad4 EAS
AF:
0.520
Gnomad4 SAS
AF:
0.737
Gnomad4 FIN
AF:
0.738
Gnomad4 NFE
AF:
0.784
Gnomad4 OTH
AF:
0.746
Alfa
AF:
0.779
Hom.:
71592
Bravo
AF:
0.752
Asia WGS
AF:
0.640
AC:
2227
AN:
3478
EpiCase
AF:
0.788
EpiControl
AF:
0.789

ClinVar

Significance: Benign
Submissions summary: Benign:16
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:8
Benign, criteria provided, single submitterclinical testingGeneDxJan 08, 2014This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 19, 2012p.Val432Val in Exon 04 of BAG3: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence and has been identified in 24.3% (909/3738) of A frican American chromosomes from a broad population by the NHLBI Exome Sequencin g Project (http://evs.gs.washington.edu/EVS; dbSNP rs196295). -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Mar 12, 2013- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Myofibrillar myopathy 6 Benign:3
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 14, 2021- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsJun 02, 2017- -
not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 04, 2017Variant summary: The BAG3 c.1296A>G (p.Val432Val) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. Mutation taster predicts a polymorphism outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. ESEfinder predicts that it affects binding of multiple ESE sites. However, these predictions have yet to be confirmed by functional studies. This variant was found in 89871/121300 control chromosomes (33720 homozygotes) from ExAC at a frequency of 0.7408986, which is approximately 18967 times the estimated maximal expected allele frequency of a pathogenic BAG3 variant (0.0000391), thus this variant is a very common benign polymorphism and allele G the wildtype allele at this position. In addition, multiple clinical diagnostic laboratories have classified this variant as benign. The variant of interest has not, to our knowledge, been reported in affected individuals in literature. Taken together, this variant is classified as benign. -
Myofibrillar myopathy 6;C3151293:Dilated cardiomyopathy 1HH Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Dilated cardiomyopathy 1HH Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMar 11, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
3.6
DANN
Benign
0.74
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs196295; hg19: chr10-121436362; COSMIC: COSV64841992; COSMIC: COSV64841992; API